Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis

BLOOD

Pavlasova, G; Borsky, M; Seda, V; Cerna, K; Osickova, J; Doubek, M; Mayer, J; Calogero, R; Trbusek, M; Pospisilova, S; Davids, MS; Kipps, TJ; Brown, JR; Mraz, M, 2016: Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis. BLOOD 128(12), p. 1609 - 1613, doi: 10.1182/blood-2016-04-709519

Research Groups:

Microenvironment of Immune Cells

CEITEC authors:

Václav Šeda, Ph.D.
Prof. Marek Mráz, Ph.D.